Abstract
A series of 2-methylthio-1,4-dihydropyrimidine derivatives (IIa–IIl) were synthesized in good yields by alkylation of 1,2,3,4-tetrahydropyrimidines (Ia–Il) with methyl iodide in the presence of pyridine. Their structures were confirmed by elemental analysis, IR, and 1H NMR spectra. Molecular docking of title compounds was done using VLife MDS 3.5 on voltage-dependent calcium channel β subunit functional core and its complex with the α1 interaction domain i.e. AID-β complex (PDB code 1T3L) to identify potential candidates with minimum dock score for cardioprotective activity. Biological screening of the potential candidates (IIf and IIi) was done for cardioprotective activity. Adult Sprague–dawley rats were pretreated with test compounds IIf and IIi. After the treatment period, adrenaline was subcutaneously injected to rats at an interval of 24 h for 2 days to induce myocardial injury. After 48 h, rats were anaesthetized and electrocardiographic (ECG) observations were performed. Potential compounds IIf and IIi showed significant cardioprotective activity against adrenaline-induced myocardial infarction in rats. Adrenaline-induced ECG alterations such as reduced R–R interval, increased heart rate, reduced P duration, and ST-segment elevation were brought to the near normal values by pretreatment of compounds IIf and IIi.
Similar content being viewed by others
References
Ahmad S, Abbas R (2005) Ionic liquid promoted efficient synthesis of 3,4-dihydropyrimidin-2-(1H)-ones. Catal Lett 100:177–179
Arfan A, Paquin L, Bazureau JP (2007) Acidic task-specific ionic liquid as catalyst of microwave-assisted solvent-free biginelli reaction. Russ J Org Chem 43:1058–1064
Bose DS, Sudharshan M, Chavhan SW (2005) New protocol for Biginelli reaction—a practical synthesis of monastrol. Arkivoc iii:228–236
Chen-Jiang L, Ji-De W (2009) Copper (II) sulfamate: an efficient catalyst for the one-pot synthesis of 3,4 dihydropyrimidine-2(1H)-ones and thiones. Molecules 14:763–770
Chikhale RV, Bhole RP, Khedekar PB, Bhusari KP (2009) Synthesis and pharmacological investigation of 3-(substituted 1-phenylethanone)-4-(substituted phenyl)-1,2,3,4-tetrahydropyrimidine-5-carboxylates. Eur J Med Chem 44:3645–3653
Chitra S, Devanathan D, Pandiarajan K (2010) Synthesis and in vitro microbiological evaluation of novel 4-aryl-5-isopropoxycarbonyl-6-methyl-3,4-dihydropyrimidinones. Eur J Med Chem 45:367–371
Ezzat R, Hadi J (2006) A practical and green approach towards synthesis of dihydropyrimidinones: using heteropoly acids as efficient catalysts. Bioorg Med Chem Lett 16:2463–2466
Fang D, Luo J, Zhou X, Ye Z, Liu Z (2007) One-pot green procedure for Biginelli reaction catalyzed by novel task-specific room-temperature ionic liquids. J Mol Catal A Chem 27:208–211
Inci SZ, Selma S, Semra CE, Kevser E (2006) Synthesis of 4-aryl-3,4-dihydropyrimidin-2(1H)-thione derivatives as potential calcium channel blockers. Bioorg Med Chem Lett 14:8582–8589
Ismaili L, Nadaradjane A, Nicod L, Guyon C, Xicluna A (2008) Synthesis and antioxidant activity evaluation of new hexahydropyrimido[5,4-c]quinoline-2,5-diones and 2-thioxohexahydropyrimido[5,4-c]quinoline-5-ones obtained by Biginelli reaction in two steps. Eur J Med Chem 43:1270–1275
Liang J-C, Chen H-R, Chiu C-C, Liou S-F, Chen I-J, Yeh J-L (2006) Protective effect of labedipinedilol-A, a novel dihydropyridine-type calcium channel blocker, on myocardial apoptosis in ischemia-reperfusion injury. Life Sci 79:1248–1256
Kappe CO (2000) Biologically active dihydropyrimidones of the Biginelli-type—a literature survey. Eur J Med Chem 3:1043–1052
Kotharkar SA, Nagawade RR, Shinde DB (2006) Chlorosulfonic acid catalyzed highly efficient solvent free synthesis of 3,4-dihydropyrimidin-2(1H)-ones and thiones. Ukrainica Bioorganica Act 2:17–21
Malhotra R, Mishra M, Kler TS, Kohli VM, Mehta Y, Trehan N (1997) Cardioprotective effects of diltiazem infusion in the perioperative period. Eur J Cardiothorac Surg 12:420–427
Mohammad A, Sadique AJ, Harish K (2008) Synthesis and biological evaluation of some 4-(1H-indol-3-yl)-6-phenyl-1,2,3,4-tetrahydropyrimidin-2-ones/thiones as potent anti-inflammatory agents. Acta Pharm 58:467–477
Mohammad A, Zahra Z (2009) 1,3-Dibromo-5,5-dimethylhydantoin as a useful reagent for efficient synthesis of 3,4-dihydropyrimidin-2-(1H)-ones under solvent-free conditions. Chem Pap 63:97–101
Rovnyak GC, Atwal KS, Hedberg A, Kimball SD, Moreland S, Gougoutas JZ, O’Reilly BC, Schwartz J, Malley MF (1992) Dihydropyrimidine calcium channel blockers. 4. Basic 3-substituted-4-aryl-1,4-dihydropyrimidine-5-carboxylic acid esters. Potent antihypertensive agents. J Med Chem 35:3254–3263
Sathish V, Ebenezar KK, Devaki T (2003) Biochemical changes on the cardioprotective effect of nicorandil and amlodipine during experimental myocardial infarction in rats. Pharmacol Res 48:565–570
Shinde SV, Jadhav WN, Lande MK, Gadekar LS, Arbad BR, Kondre JM, Karade NN (2008) Scolecite as a novel heterogeneous acid catalyst for an efficient synthesis of 3,4-dihydropyrimidin-2(1H)-ones via multi-component biginelli reaction. Catal Lett 125:57–61
Snider BB, Chen J (1998) Synthesis of batzelladine E and its E isomer. Tetrahedron Lett 39:5697–5700
Teodoro ML, Phillips GN, Kavraki LE (2001) Molecular docking: a problem with thousands of degree of freedom. Robotics Autom 1:960–965
Yang Y, Di L, Chunsheng L, Genxiang L (2007) One-pot synthesis of 3,4-dihydropyrimidin-2(1H)-ones using chloroacetic acid as catalyst. Bioorg Med Chem Lett 17:3508–3510
Zucchi R, Ronca F, Ronca-Testoni S (2001) Modulation of sarcoplasmic reticulum function: a new strategy in cardioprotection. Pharmacol Ther 89:47–65
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sawant, R.L., Sarode, V.I., Jadhav, G.D. et al. Synthesis, molecular docking, and cardioprotective activity of 2-methylthio-1,4-dihydropyrimidines. Med Chem Res 21, 1825–1832 (2012). https://doi.org/10.1007/s00044-011-9700-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00044-011-9700-7